{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:36:38Z","timestamp":1769740598917,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejso.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T11:37:27Z","timestamp":1550489847000},"page":"1417-1424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuru","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.02.019_bib1","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/jog.13043","article-title":"Annual report of the committee on gynecologic Oncology, Japan society of obstetrics and gynecology: patient Annual report for 2013 and treatment annual report for 2008","volume":"42","author":"Saito","year":"2016","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ejso.2019.02.019_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/IGC.0000000000000202","article-title":"Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (Bulky Tumors) in Japan: a survey of the Japanese Gynecologic Oncology Group","volume":"24","author":"Mikami","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2019.02.019_bib3","unstructured":"National Comprehensive Cancer Network Clinical Practice Guideline in Oncology. Cervical Cancer. <https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf> (accessed 1\/29\/2019)."},{"key":"10.1016\/j.ejso.2019.02.019_bib4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/ijgc-00009577-200511000-00001","article-title":"Radical hysterectomy for stage IIB cervical cancer: a review","volume":"15","author":"Suprasert","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2019.02.019_bib5","first-page":"e156","article-title":"Neoadjuvant chemotherapy with taxane and platinum followed by radical hysterectomy for stage IB2-IIB cervical cancer: impact of histology type","volume":"8","author":"Matsuo","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ejso.2019.02.019_bib6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ijc.31084","article-title":"Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer","volume":"142","author":"Matsuo","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2019.02.019_bib7","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3802\/jgo.2018.29.e11","article-title":"Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer","volume":"29","author":"Matsuo","year":"2018","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib8","doi-asserted-by":"crossref","first-page":"106866","DOI":"10.18632\/oncotarget.22437","article-title":"Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer","volume":"8","author":"Matsuo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2019.02.019_bib9","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3802\/jgo.2017.28.e60","article-title":"Ovarian conservation for young women with clinical stage IB-IIB cervical cancer in Japan","volume":"28","author":"Matsuo","year":"2017","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ijc.30793","article-title":"Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: systemic chemotherapy versus pelvic irradiation","volume":"141","author":"Matsuo","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2019.02.019_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10147-015-0806-7","article-title":"Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer","volume":"20","author":"Ebina","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib12","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.3802\/jgo.2018.29.e10","article-title":"Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer","volume":"29","author":"Matsuo","year":"2018","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A\u00a0comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2019.02.019_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2019.02.019_bib15","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2019.02.019_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2019.02.019_bib17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00330-010-1998-x","article-title":"Staging of uterine cervical cancer with MRI: guidelines of the European society of urogenital Radiology","volume":"21","author":"Balleyguier","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2019.02.019_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clinimag.2015.09.012","article-title":"Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature","volume":"40","author":"Bourgioti","year":"2016","journal-title":"Clin Imaging"},{"key":"10.1016\/j.ejso.2019.02.019_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2014.02.042","article-title":"Preoperative MRI criteria for trials on less radical surgery in Stage IB1 cervical cancer","volume":"134","author":"Lee","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-015-1184-2","article-title":"Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2019.02.019_bib21","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00330-013-2783-4","article-title":"Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis","volume":"23","author":"Thomeer","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2019.02.019_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2015.01.548","article-title":"Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)","volume":"137","author":"Kato","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/bjc.2013.78","article-title":"Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer","volume":"108","author":"Matsuo","year":"2013","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2019.02.019_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3802\/jgo.2015.26.1.3","article-title":"Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors","volume":"26","author":"Matsuo","year":"2015","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.019_bib26","unstructured":"Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy. NIH U.S. National Library of Medicine, ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00980954 (accessed 1\/29\/2019)."}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319302902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319302902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:30:39Z","timestamp":1760059839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319302902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0748798319302902"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.019","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}